Notice of Withdrawal
Notice of Withdrawal
2025 Volume 48 Issue 3 Pages 336
Details
2025 Volume 48 Issue 3 Pages 336
Withdrawal:
Vol./Page: Biol. Pharm. Bull. 47, 2127–2137 (2024)
Title: Serum DLAT Is a Potential Diagnostic Marker in AFP-Negative HCC
Authors: Fangfang Huang, Jindong Bai, Limei Hu, Changliang Luo, and Leping Ning
Author’s Comments:
The author checked the article and found that there was a citation error in this article. In the statement “Evidence shows that DLAT participates in acetylation of glucose 6-phosphate dehydrogenase (6PGD) and histone acetylation,4,23,24) thus DLAT may plays an important role in gene transcription and metabolic regulation,” the cited articles do not mention that DLAT participates in histone acetylation. Finally, the source of the samples does not match the affiliated institutions of researchers, which may lead to issues of improper authorship.
Changliang Luo and Leping Ning
Department of Laboratory Medicine, The People’s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, Guangxi Zhuang Autonomous Region 530021, China
February 12, 2025
Editorial Decision:
This article has been deleted at the request of the authors from this journal.
Editorial Committee of the Pharmaceutical Society of Japan (February 17, 2025)
